comparing glp-1 agonists GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults GLP-1 Agonist Drugs I -
Description
Chen Y-C, Chen T-H, Sun -C-C, et al
25 This damage culminates in geographic atrophy or disruption of Bruchs membrane, leading to severe vision loss and, in some cases, neovascularization
If you miss a dose of liraglutide (Victoza or Saxenda), take the next usual dose the next day
Other GLP-1 RAs, showed neutral effects
That falls short of tirzepatide numbers, but phentermine offers several advantages: it is available as a generic, costs as little as $15-30 per month, requires no injections, and works almost immediately
This mechanistic diversity suggests that GLP-1RAs could be repurposed to target complex, multifactorial disorders like schizophrenia, bipolar disorder, and bulimia nervosa, where current treatment options are limited or suboptimal
